摘要
拉考沙胺(1acosamide)也称拉科酰胺,商品名Vimpat。2008年10月28日获FDA批准,由德国Schwarz BioSciences公司研发生产,是近3年来首个治疗癫痫部分发作的抗癫痫新药,对未控制的癫痫部分发作患者提供了治疗新手段。拉考沙胺的新颖作用模式不同于目前临床所用的所有抗癫痫药,
出处
《药物流行病学杂志》
CAS
2010年第8期476-478,共3页
Chinese Journal of Pharmacoepidemiology
参考文献10
-
1Beydoun A, DSouza J, Hebert D,et al. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures[J]. Expert Rev Neurother, 2009,9( 1 ) :33-42.
-
2Kellinghaus C. Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety [ J]. Ther Clin Risk Manag, 2009,5:757-766.
-
3Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, et al. Adjunctive lacosamide for partial - onset seizures: Efficacy and safety results from a randomized controlled trial[ J ]. Epilepsia, 2009, 50(3):443-453.
-
4Ben-Menachem E, Biton V, Jatuzis D, et al. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures [ J ]. Epilepsia, 2007, 48 ( 7 ) : 1308- 1317.
-
5Beyreuther BK, Geis C, Stohr T, et al. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF [ J ]. Neuropharmacology JT-Neuropharmacology. 2007, 52(5) :1312-1327.
-
6Halford JJ, Lapointe M. Clinical perspectives on lacosamide [ J]. Epilepsy Curr JT-Epilepsy currents ! American Epilepsy Society,2009,9( 1 ) : 1-9.
-
7Wymer JP, Simpson J, Sen D,et al. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double- blind placebo-controlled trial of fixed-dose regimens [ J ]. Clin J Pain JT- The Clinical journal of pain, 2009,25 (5) :376-385.
-
8Errington AC, Stohr T, Heers C, et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels [ J ]. Mol Pharmacol JT-Molecular pharmacology ,2008,7 ( 31 ) : 157-169.
-
9Tilz C, Resch R, Hofer T, et al. Successful treatment for refractory convulsive status epilepticus by parenteral lacosamide [ J ]. Epilepsia JT-Epilepsia,2009 , 8 (25) : 131-156.
-
10Shaibani A, Biton V, Rauck R, et al. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial [ J ]. Eur J Pain JT European journal of pain ( London, England) ,2009,13 ( 5 ) :458-463.
同被引文献66
-
1范丽珠(摘).Lacosamide可减少惊厥14.4%[J].国外药讯,2007(7):18-19. 被引量:2
-
2于瑞,王兴涌.抗癫痫药物拉科酰胺的合成路线综述[J/OL],中国科技论文在线,[2011-09-02].
-
3BOUVY D, MERSCHAERT A, PINILLA V,etalNovel Process for the Preparation of Amino Acid De-rivatives: WO,2010052011A1[P], 2010-05-14.
-
4BEGUIN C, TIRAN A L,STABLES J P, et aL N~Substituted Amino Acid N-Benzylamides: Synthesis,Anticonvulsant, and Metabolic Activities [J]. BioorgMed Chem, 2004, 12(11): 3079-3096.
-
5KIM J D, HAN G, JEONG L S, et al. Study of theStability of Carbocations by Chlorosulfonyl IsocyanateReaction with Ethers[J]. Tetrahedron,2002’ 58(22):4395-4402.
-
6Nahar Lutfun, Turner Alan B. Synthesis of Dinor-cholane and 5(3-Cholane Derivatives [ J]. Journal ofChemical Research, 2004? (5) : 329-332.
-
7王蓓,许文松.混合酸酐法合成L-脯氨酰-L-亮氨酰-甘氨酰胺(PLG)三肽[D].杭州:浙江大学,2006.
-
8FRANC M F, CHEN Young-lee et al. Mixed An-hydrides in Peptide Synthesis. A Study of UrethaneFormation with a Contribution on Minimization of Rac-emization [J]. Can J Chem. 1987, 65: 613-618.
-
9Pamela Doty, Rudd G David,Thomas Stoehr, et al. Lacosamide[J].Neurotherapeutis,2007,4(1): 145-148.
-
10Adam C Errington, Leanne Coyne, Thomas Stohr, et al. Seeking amechanism of action for the novel anticonvulsant lacosamide [J].Neuropharmacology, 2006,50 (8): 1016-1029.
引证文献8
-
1靳淑云,俞迪虎,李勇.混合酸酐法合成N-苄基-2-溴-3-甲氧基丙酰胺的杂质研究[J].化学世界,2013,54(1):22-25. 被引量:2
-
2卢定强,孙生柏,凌岫泉,王琦,夏芙洁.拉科酰胺的合成研究进展[J].化工进展,2013,32(12):2961-2966. 被引量:3
-
3彭海燕,蔡润发,廖祝元,曾繁荣,范卫永.拉科酰胺中脲类化合物杂质的合成及结构鉴定[J].赣南师范学院学报,2016,37(6):69-71. 被引量:1
-
4纪忠兆,王桂艳.拉科酰胺的合成工艺改进[J].广东化工,2018,45(8):31-32. 被引量:1
-
5欧阳婷,曾祥盛,罗恒真,廖祝元.电感耦合等离子体质谱法测定拉考沙胺注射液中10种杂质元素[J].理化检验(化学分册),2020,56(2):211-215. 被引量:4
-
6魏勇翔,欧阳汝霖,钟仁清,罗福菖,梁佳,蔡润发,陈文北,魏东.拉科酰胺部分主要酰胺类杂质对照品合成与研究[J].江西化工,2022,38(2):79-82.
-
7惠大永,袁红芹,党珍,梁帆,赵伟静,李炜.拉考沙胺原料药粒度分析方法研究[J].当代化工研究,2022(15):37-40.
-
8赵妍,凌云.拉考沙胺联合丙戊酸钠治疗难治性癫痫的效果研究[J].中国药物滥用防治杂志,2024,30(1):10-14.
二级引证文献11
-
1吴怀秀,王军娟,胡剀,宋珊珊,王向军.RRLC-QTOF鉴定拉科酰胺的未知杂质[J].中国现代应用药学,2014,31(5):563-566. 被引量:5
-
2王晓平,李青.L-苯丙氨酸衍生物凝胶因子的合成研究[J].北京服装学院学报(自然科学版),2015,35(3):55-60.
-
3吕志排,曹静,王举,刘琼丽.拉科酰胺对骨关节炎大鼠疼痛行为学的影响[J].河南医学研究,2017,26(8):1357-1359.
-
4李桂林,孙国龙,张春鸽,赵巧辉,付光宇,吴学炜.混合酸酐法合成雌二醇酶标抗原偶联工艺影响因素探讨[J].医药论坛杂志,2017,38(9):58-60. 被引量:3
-
5纪忠兆,王桂艳.拉科酰胺的合成工艺改进[J].广东化工,2018,45(8):31-32. 被引量:1
-
6陈梦迪,杨安江,张晓庆,张福利,赵春杰.拉科酰胺原料药中有关物质的合成[J].中国药物化学杂志,2019,29(3):219-223.
-
7吴法浩.非天然手性氨基酸合成的研究进展[J].生物化工,2020,6(1):122-125. 被引量:3
-
8朱俐,张才煜,赵瑜,许明哲.电感耦合等离子体质谱法测定烟酰胺药物元素杂质[J].分析试验室,2021,40(12):1455-1460. 被引量:2
-
9朱俐,赵瑜,肖超强,许明哲,尹利辉.电感耦合等离子体质谱法测定盐酸头孢卡品酯颗粒中9种元素杂质的含量[J].理化检验(化学分册),2022,58(5):512-516. 被引量:3
-
10乔敏莎,郑秋莹,乔晓娜,张绿茵,兰为环,路晓慧,潘晓男.微波消解-电感耦合等离子体质谱法测定DPP-4抑制剂原料药中7种元素杂质[J].化工与医药工程,2023,44(3):23-28.
-
1谢佳星,梁标.抗氧化剂硒的研究进展[J].右江医学,2003,31(6):598-600. 被引量:3
-
2魏振满,丁晋彪,胡琳,陈红鸽,孙斌,宫雯雯,刘峰群.拉米夫定片人体生物等效性研究[J].中国药业,2011,20(1):9-11. 被引量:1
-
3郭秒,郭继芬,虞林,王以美,贾栗,彭双清,袁波.LC-MS/MS法测定大鼠血浆中芍药内酯苷的浓度及其在毒代动力学研究中的应用[J].国际药学研究杂志,2017,44(3):273-277. 被引量:1
-
4北京康仁堂药业有限公司[J].环球中医药,2012,5(1).
-
5胡剀,宋珊珊,王向军.GC测定拉科酰胺原料药中的5种残留溶剂[J].中国现代应用药学,2014,31(3):343-345. 被引量:2
-
6金荣庆.硒防治疾病的药理作用[J].现代中西医结合杂志,2002,11(24):2531-2531. 被引量:1
-
7抗癫痫药[J].世界临床药物,2010(1):63-63.
-
8王凯,张雄,金琪,张秀兰,张珩.拉科酰胺的合成[J].中国医药工业杂志,2014,45(7):603-605.
-
9马银玲,赵锋,张恺,刘磊娜,杜玉民.拉科酰胺的合成[J].中国医药工业杂志,2009,40(9):641-643. 被引量:4
-
10汪琛,陈卉,杨剑云.HPLC测定拉科酰胺原料药的含量及其有关物质[J].航空航天医学杂志,2011,22(6):665-666.